(NYSE: NVST) Envista Holdings's forecast annual revenue growth rate of 3.09% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.72%.
Envista Holdings's revenue in 2025 is $2,503,900,000.On average, 7 Wall Street analysts forecast NVST's revenue for 2025 to be $432,696,615,475, with the lowest NVST revenue forecast at $425,790,189,182, and the highest NVST revenue forecast at $439,174,748,086. On average, 7 Wall Street analysts forecast NVST's revenue for 2026 to be $448,468,568,443, with the lowest NVST revenue forecast at $440,539,965,975, and the highest NVST revenue forecast at $459,157,266,918.
In 2027, NVST is forecast to generate $465,203,038,159 in revenue, with the lowest revenue forecast at $453,619,956,717 and the highest revenue forecast at $476,546,634,452.